NASDAQ: BRKR | Healthcare / Medical Devices & Instruments / USA |
62.77 | +1.67 | +2.73% | Vol 502.77K | 1Y Perf 8.56% |
Oct 4th, 2023 16:00 DELAYED |
BID | 61.63 | ASK | 64.66 | ||
Open | 61.36 | Previous Close | 61.10 | ||
Pre-Market | - | After-Market | 62.12 | ||
- - | -0.65 -1.04% |
Target Price | 73.50 | Analyst Rating | Moderate Buy 2.11 | |
Potential % | 17.09 | Finscreener Ranking | ★★ 46.39 | |
Insiders Trans % 3/6/12 mo. | 100/-60/-82 | Value Ranking | ★★ 45.83 | |
Insiders Value % 3/6/12 mo. | 100/-97/-100 | Growth Ranking | ★★★★ 59.78 | |
Insiders Shares Cnt. % 3/6/12 mo. | 100/-97/-99 | Income Ranking | + 26.30 | |
Price Range Ratio 52W % | 32.34 | Earnings Rating | Sell | |
Market Cap | 9.22B | Earnings Date | 2nd Nov 2023 | |
Alpha | 0.01 | Standard Deviation | 0.09 | |
Beta | 1.13 |
Today's Price Range 61.1162.87 | 52W Range 52.2284.84 | 5 Year PE Ratio Range 22.3089.70 |
Summary:
Sell
Technical Indicators: | Sell |
Moving Averages: | Strong Sell |
Performance | |||
---|---|---|---|
1 Week | 0.54% | ||
1 Month | -1.85% | ||
3 Months | -14.34% | ||
6 Months | -19.99% | ||
1 Year | 8.56% | ||
3 Years | 59.12% | ||
5 Years | 86.82% | ||
10 Years | 201.78% |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | 14.47 | |||
ROE last 12 Months | 29.75 | |||
ROA (5Y Avg) | 3.84 | |||
ROA last 12 Months | 9.18 | |||
ROC (5Y Avg) | 9.96 | |||
ROC last 12 Months | 13.77 | |||
Return on invested Capital Q | 4.14 | |||
Return on invested Capital Y | 3.47 | |||
Assets Turnover | 0.60 | |||
Receivables Turnover | 4.70 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
37.00 | ||||
10.58 | ||||
5.29 | ||||
42.00 | ||||
-99.50 | ||||
1.60 | ||||
29.02 | ||||
6.37 | ||||
10.44B | ||||
Forward PE | 21.40 | |||
PEG | 2.00 |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
1.20 | ||||
2.40 | ||||
0.55 | ||||
1.22 | ||||
34.50 | ||||
Leverage Ratio | 3.50 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
51.00 | ||||
17.40 | ||||
20.90 | ||||
14.40 | ||||
10.99 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
1.82B | ||||
12.39 | ||||
6.74 | ||||
7.16 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
0.31 | ||||
0.20 | ||||
0.59 | ||||
0.26 | ||||
Payout ratio | 12.00 |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q02 2023 | 0.48 | 0.50 | 4.17 |
Q01 2023 | 0.55 | 0.64 | 16.36 |
Q04 2022 | 0.72 | 0.74 | 2.78 |
Q03 2022 | 0.53 | 0.66 | 24.53 |
Q02 2022 | 0.45 | 0.45 | 0.00 |
Q01 2022 | 0.41 | 0.49 | 19.51 |
Q04 2021 | 0.59 | 0.59 | 0.00 |
Q03 2021 | 0.45 | 0.63 | 40.00 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
9/2023 QR | 0.63 | -7.35 | Negative |
12/2023 QR | 0.81 | 5.19 | Positive |
12/2023 FY | 2.57 | -0.39 | Negative |
12/2024 FY | 2.91 | 0.00 | - |
Next Report Date | 2nd Nov 2023 |
Estimated EPS Next Report | 0.63 |
Estimates Count | 7 |
EPS Growth Next 5 Years % | 18.50 |
Volume Overview | |
---|---|
Volume | 502.77K |
Shares Outstanding | 146.85K |
Shares Float | 97.95M |
Trades Count | 11.56K |
Dollar Volume | 31.30M |
Avg. Volume | 784.01K |
Avg. Weekly Volume | 556.14K |
Avg. Monthly Volume | 927.56K |
Avg. Quarterly Volume | 868.33K |
Bruker Corporation (NASDAQ: BRKR) stock closed at 62.77 per share at the end of the most recent trading day (a 2.73% change compared to the prior day closing price) with a volume of 502.77K shares and market capitalization of 9.22B. Is a component of Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 7230 people. Bruker Corporation CEO is Frank H. Laukien.
The one-year performance of Bruker Corporation stock is 8.56%, while year-to-date (YTD) performance is -8.16%. BRKR stock has a five-year performance of 86.82%. Its 52-week range is between 52.22 and 84.84, which gives BRKR stock a 52-week price range ratio of 32.34%
Bruker Corporation currently has a PE ratio of 37.00, a price-to-book (PB) ratio of 10.58, a price-to-sale (PS) ratio of 5.29, a price to cashflow ratio of 42.00, a PEG ratio of 2.00, a ROA of 9.18%, a ROC of 13.77% and a ROE of 29.75%. The company’s profit margin is 10.99%, its EBITDA margin is 20.90%, and its revenue ttm is $1.82 Billion , which makes it $12.39 revenue per share.
Of the last four earnings reports from Bruker Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.63 for the next earnings report. Bruker Corporation’s next earnings report date is 02nd Nov 2023.
The consensus rating of Wall Street analysts for Bruker Corporation is Moderate Buy (2.11), with a target price of $73.5, which is +17.09% compared to the current price. The earnings rating for Bruker Corporation stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Bruker Corporation has a dividend yield of 0.31% with a dividend per share of $0.20 and a payout ratio of 12.00%.
Bruker Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 14.60, ATR14 : 1.71, CCI20 : -86.02, Chaikin Money Flow : -0.10, MACD : -0.98, Money Flow Index : 48.89, ROC : -8.02, RSI : 39.44, STOCH (14,3) : 3.43, STOCH RSI : 0.00, UO : 40.25, Williams %R : -96.57), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Bruker Corporation in the last 12-months were: Cynthia M. Friend (Sold 921 shares of value $62 867 ), Frank H. Laukien (Sold 1 000 000 shares of value $77 623 552 ), Friend Cynthia (Sold 921 shares of value $62 867 ), Herman Gerald (Sold 14 242 shares of value $1 074 131 ), Kastner Marc (Sold 11 146 shares of value $838 402 ), Marc A. Kastner (Option Excercise at a value of $240 000), Marc A. Kastner (Sold 10 000 shares of value $707 490 ), Richard A. Packer (Option Excercise at a value of $164 200), Richard A. Packer (Sold 20 000 shares of value $1 323 660 ), William A. Linton (Option Excercise at a value of $164 200)
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Moderate Buy | Moderate Buy | Moderate Buy |
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. The vast majority of revenue comes from the scientific instruments segment, which develops tools based on magnetic resonance, mass spectrometry, and X-ray technologies. The remainder of the firm's business comes from the energy and superconductor technology segment, which manufactures superconducting materials primarily used in magnetic resonance imaging, nuclear magnetic resonance, and fusion energy research. The largest proportion of Bruker's revenue comes from Europe, though the firm also has a significant presence in the United States and Asia.
CEO: Frank H. Laukien
Telephone: +1 978 663-3660
Address: 40 Manning Road, Billerica 01821, MA, US
Number of employees: 7 230
Tue, 22 Aug 2023 20:11 GMT PhenomeX downgraded to Market Perform from Outperform at TD Cowen
- TipRanks. All rights reserved.Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Copyright © 2023. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer.
General partner of Finscreener is SLOVAKODATA, a.s.
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.